ALOPECIA AREATA
Clinical trials for ALOPECIA AREATA explained in plain language.
Never miss a new study
Get alerted when new ALOPECIA AREATA trials appear
Sign up with your email to follow new studies for ALOPECIA AREATA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aimed at regrowing hair in severe alopecia
Disease control TerminatedThis study tested a drug called amlitelimab in 166 adults with severe alopecia areata, a condition causing significant hair loss. Participants received either the drug or a placebo by injection. The main goal was to see if the drug could reduce hair loss scores after 36 weeks. Th…
Matched conditions: ALOPECIA AREATA
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New pill shows promise for severe baldness, but trial cut short
Disease control TerminatedThis study tested a drug called KL130008 in 114 adults with severe alopecia areata, a condition causing major hair loss. The goal was to see if the drug could safely regrow hair, measured by how many people achieved 80% or more scalp coverage. However, the trial was terminated ea…
Matched conditions: ALOPECIA AREATA
Phase: PHASE2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Hair loss ointment study halted early – only 4 people enrolled
Disease control TerminatedThis study tested a custom ointment called DPCP to help people with severe alopecia areata, a condition causing patchy or complete scalp hair loss. The goal was to see if the ointment could safely regrow hair. Only 4 people took part before the study was stopped early, so results…
Matched conditions: ALOPECIA AREATA
Phase: PHASE3 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC